JNJ: Summary for JOHNSON AND JOHNS DC - Yahoo! Canada Finance

MORE ON JNJ

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

JOHNSON AND JOHNS DC (NYSE:JNJ) Delayed quote data

Pre-Market: 63.16

0.40 (0.64%) as of 7:47am EST on 02/10/10

Last Trade:	62.76 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	62.76
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	74.00

Day's Range:	N/A - N/A
52wk Range:	46.25 - 65.95
Volume:	900
Avg Vol (3m):	11,418,000
Market Cap:	173.16B
P/E (ttm):	17.27
EPS (ttm):	3.63
Div & Yield:	1.93 (3.08%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add JNJ to Portfolio

Download Data

HEADLINES

•	The Toyota Recall: Understanding the Real Problem
	at BusinessWeek (Wed 8:08am)

•	Don't Sell This Stock. Ever.
	at Motley Fool (Wed 7:00am)

•	Irish drugmaker Elan slumps to Q4 loss
	AP (Wed 6:25am)

•	[$$] Elan Swings to a Loss
	at The Wall Street Journal Online (Wed 6:21am)

•	Four Stocks to Keep an Eye On
	at TheStreet.com (Wed 6:00am)

•	[video] How to Find the Buying Opportunities
	at TheStreet.com (Wed 6:00am)

•	The Case For Corporate Bonds
	at Forbes.com (Wed 6:00am)

•	Elan expects first operating profit in years
	at FT.com (Wed 4:40am)

•	Stress Relief Online, Aromatherapy by Mail
	at The New York Times (Wed 2:17am)

•	What U.S. Investments Does China Like?
	at Seeking Alpha (Tue 5:51pm)

•	BBH Core Select's Weightings Shift
	Investor's Business Daily (Tue 5:30pm)

More Headlines for JNJ...

ANALYST

EPS Est (next year) (Dec-08) :	4.43
EPS Est (in 2 years) (Dec-09) :	4.68
Avg Rec (current)*:	2.0
PEG Ratio:	1.88

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Johnson & Johnson engages in the manufacture and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Johnson & Johnson (JNJ)